Angiotensin-Converting Enzyme Inhibitor-Induced Non-allergic Perioral Angioedema: A Case-Based Scoping Review
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Patients with angiotensin-converting enzyme inhibitor (ACEI)-induced angioedema (ACEIIA) may visit family physicians. The aim of this article was to describe a case of delayed-onset ACEIIA and to present a concise scoping review. Using a case report and a scoping review study design, we report a case of ACEIIA, with clinically confirmed diagnosis. The symptoms resolved after replacing the offending ACEI with another antihypertensive agent. After excluding other causes of perioral swelling and discontinuation of ACEI, the patient was symptom-free within a few days thereafter. Based on this case presentation, we performed a meta-narrative scoping review including up-to-date diagnosis and management of ACEIIA, based on published data in English, French, and German from incep-tion to April 1, 2021. Patients with angioedema of unknown origin should be cautiously examined to rule out oral diseases, including allergy to dental materials and drug-induced angioedema. Clinicopathological aspects and current treatment guidelines for ACEI-associated angioedema are also presented.
Abstract
Patients with angiotensin-converting enzyme inhibitor (ACEI)-induced angioedema (ACEIIA) may visit family physicians. The aim of this article was to describe a case of delayed-onset ACEIIA and to present a concise scoping review. Using a case report and a scoping review study design, we report a case of ACEIIA, with clinically confirmed diagnosis. The symptoms resolved after replacing the offending ACEI with another antihypertensive agent. After excluding other causes of perioral swelling and discontinuation of ACEI, the patient was symptom-free within a few days thereafter. Based on this case presentation, we performed a meta-narrative scoping review including up-to-date diagnosis and management of ACEIIA, based on published data in English, French, and German from incep-tion to April 1, 2021. Patients with angioedema of unknown origin should be cautiously examined to rule out oral diseases, including allergy to dental materials and drug-induced angioedema. Clinicopathological aspects and current treatment guidelines for ACEI-associated angioedema are also presented.
참고문헌 (29)
- Rai R, "Investigation of contact allergy to dental materials by patch testing", Indian Dermatol Online J, 5, pp.282~286 (2014)
- (2011)[URL]
- Mihaela Leru P, "Acquired angioedema induced by angiotensin-converting enzyme inhibitors : experience of a hospital-based allergy center", Exp Ther Med, 20, pp.68~72 (2020)
- (2015)[URL]
- Davin L, "Angioedema : a rare and sometimes delayed side effect of angiotensin-converting enzyme inhibitors", Acta Cardiol, 74, pp.277~281 (2019)
- Montinaro V, "ACE inhibitor-mediated angioedema", Int Immunopharmacol, 78, pp.106081~ (2020)
- Misra L, "Angioedema : classification, management and emerging therapies for the perioperative physician", Indian J Anaesth, 60, pp.534~541 (2016)
- Kalambay J, "Pathogenesis of drug induced non-allergic angioedema: a review of unusual etiologies", Cureus, pp.e1598~ (2017)
- Sachs B, "Drug-induced angioedema : focus on bradykinin", Hautarzt, 69, pp.298~305 (2018)
- (2012)[URL]
- Kanani A, "Urticaria and angioedema", Allergy Asthma Clin Immunol, 14(Suppl 2), pp.59~ (2018)
- Bork K, "Recurrent angioedema and the threat of asphyxiation", Dtsch Arztebl Int, 107, pp.408~414 (2010)
- A Cesoni Marcelli, "Nailfold Videocapillaroscopy Findings in Bradykinin-Mediated Angioedema", Journal of Investigational Allergy and Clinical Immunology, 31(5), pp.404~416 (2021), Esmon Publicidad[DOI]
- Rasmussen ER, "Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment", Pharmacogenomics J, 20, pp.770~783 (2020)
- Kostis WJ, "ACE inhibitor-induced angioedema : a review", Curr Hypertens Rep, 20, pp.55~ (2018)
- Krause AJ, "An unusual presentation of ACE inhibitor-induced visceral angioedema", BMJ Case Rep, 12, pp.e230865~ (2019)
- Parreira R, "ACE inhibitor-induced small bowel angioedema, mimicking an acute abdomen", J Surg Case Rep, 2020, pp.rjaa348~ (2020)
- Dubrall D, "Angioedemas associated with renin-angiotensin system blocking drugs : comparative analysis of spontaneous adverse drug reaction reports", PLoS One, 15, pp.e0230632~ (2020)
- Hahn J, "The ulm emergency algorithm for the acute treatment of drug-induced, bradykinin-mediated angioedema", Med Klin Intensivmed Notfmed, 114, pp.708~716 (2019)
- Ciancio SG, "Medications’ impact on oral health", J Am Dent Assoc, 135, pp.1440~1448 (2004)
- "Presse Med", 2019, 55~62
- Wang K, "Tranexamic acid for ACE inhibitor induced angioedema", Am J Emerg Med, 43, pp.292~ (2021)
- Maertins M, "Angioedema after administration of tPA for ischemic stroke : case report", Air Med J, 30, pp.276~278 (2011)
- Chiu AG, "Angioedema associated with angiotensin II receptor antagonists : challenging our knowledge of angioedema and its etiology", Laryngoscope, 111, pp.1729~1731 (2001)
- Mudd PA, "Emergency department evaluation of patients with angiotensin converting enzyme inhibitor associated angioedema", Am J Emerg Med, 38, pp.2596~2601 (2020)
- "Dtsch Zahnarztl Z", 2013, 669~676, https:
- Bas M, "ACE inhibitor-induced angioedema in the head and neck region : a matter of time?", HNO, 52, pp.886~890 (2004)
- Pfeffer MA, "Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both", N Engl J Med, 349, pp.1893~1906 (2003)